SNA vs VYNE · P/E 17, rev $1.33B vs rev $501.0K
Snap-On Inc (SNA) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
Snap-On Inc (SNA) is a tools & accessories company listed on US.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported SNA revenue for 2026-07-04 was $1.33B. Net income was $260.6M. Revenue was up 2.0% from 2026-04-04 to 2026-07-04. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
SNA currently screens at market cap $16.82B and trailing P/E 16.8. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the SNA and VYNE stock pages for the full models.
Not investment advice.